Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer
Aim To estimate annual societal costs associated with chemotherapy for early breast cancer in the UK.Design Mixed methods: (a) an incidence-based cost-of-illness model was developed of indirect costs in patients with breast cancer and carers, and estimated from diagnosis through active treatment unt...
Main Authors: | Anita Patel, Richard Fordham, Krishnali Parsekar, Stephanie Howard Wilsher, Anna Sweeting |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/1/e039412.full |
Similar Items
-
Cost of illness of atrial fibrillation: a nationwide study of societal impact
by: Søren Paaske Johnsen, et al.
Published: (2017-11-01) -
Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis
by: Mohammad M. H. Abdullah, et al.
Published: (2017-07-01) -
The societal costs of insomnia
by: Alan G Wade
Published: (2010-12-01) -
Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco
by: Boutayeb Saber, et al.
Published: (2010-09-01) -
Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK
by: Humphreys S, et al.
Published: (2013-08-01)